Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China flag China · Delayed Price · Currency is CNY
11.16
-0.23 (-2.02%)
Mar 19, 2026, 1:45 PM CST

SHE:002399 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
15,20214,15215,34517,09022,78723,671
Market Cap Growth
0.98%-7.78%-10.21%-25.00%-3.74%-2.72%
Enterprise Value
15,25815,45619,08319,99224,28125,891
Last Close Price
11.3910.4711.4912.4716.5616.52
PE Ratio
39.8421.88-23.4994.6323.11
Forward PE
19.4720.6624.0614.6431.0920.26
PS Ratio
2.822.692.832.393.584.44
PB Ratio
1.221.161.281.381.982.03
P/TBV Ratio
1.571.491.661.812.622.71
P/FCF Ratio
9.007.10----
P/OCF Ratio
8.256.4538.53--634.89
EV/Sales Ratio
2.832.943.512.793.824.86
EV/EBITDA Ratio
19.7615.05180.7015.7122.0120.11
EV/EBIT Ratio
31.5420.72-20.0229.1325.54
EV/FCF Ratio
9.037.75----
Debt / Equity Ratio
0.250.290.460.520.490.48
Debt / EBITDA Ratio
3.373.3338.644.954.984.28
Debt / FCF Ratio
1.831.78----
Net Debt / Equity Ratio
00.070.270.240.150.17
Net Debt / EBITDA Ratio
0.000.8530.082.371.571.58
Net Debt / FCF Ratio
00.44-81.01-3.08-8.62-11.59
Asset Turnover
0.310.290.270.360.330.31
Inventory Turnover
0.730.580.670.841.111.19
Quick Ratio
1.161.090.760.941.191.52
Current Ratio
2.392.602.132.222.252.53
Return on Equity (ROE)
3.23%5.17%-6.58%5.97%2.01%10.66%
Return on Assets (ROA)
2.22%2.55%-0.68%3.13%2.73%3.70%
Return on Invested Capital (ROIC)
4.21%4.55%-1.42%6.00%6.18%5.98%
Return on Capital Employed (ROCE)
4.70%5.50%-1.50%6.60%5.80%6.60%
Earnings Yield
2.76%4.57%-5.10%4.26%1.06%4.33%
FCF Yield
11.11%14.09%-0.26%-5.73%-0.88%-0.74%
Dividend Yield
2.19%2.39%-0.80%0.21%0.91%
Payout Ratio
68.39%--34.51%171.31%43.69%
Buyback Yield / Dilution
0.56%0.54%-0.67%-0.05%-8.42%-8.51%
Total Shareholder Return
2.75%2.93%-0.67%0.75%-8.21%-7.60%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.